These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 17960066

  • 1. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [Abstract] [Full Text] [Related]

  • 2. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K.
    Transplantation; 2003 Feb 15; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [Abstract] [Full Text] [Related]

  • 3. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May 15; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S, Lee SG, Joh JW, Suh KS, Kim DG.
    Liver Transpl; 2005 Oct 15; 11(10):1265-72. PubMed ID: 16184545
    [Abstract] [Full Text] [Related]

  • 5. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
    Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y.
    Transplantation; 2007 Apr 15; 83(7):893-9. PubMed ID: 17460559
    [Abstract] [Full Text] [Related]

  • 6. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, Miyamoto A, Takeda Y, Umeshita K, Monden M.
    Transpl Int; 2007 Jul 15; 20(7):576-82. PubMed ID: 17425725
    [Abstract] [Full Text] [Related]

  • 7. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar 15; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 15; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 9. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S.
    Transplant Proc; 2012 Apr 15; 44(6):1713-6. PubMed ID: 22841251
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul 15; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 11. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 12. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
    Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, Ogawa K, Ogura Y, Oike F, Egawa H, Uemoto S.
    Dig Dis; 2007 Apr 27; 25(4):299-302. PubMed ID: 17960063
    [Abstract] [Full Text] [Related]

  • 13. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 27; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 14. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.
    Transplant Proc; 2011 Dec 27; 43(10):3813-8. PubMed ID: 22172852
    [Abstract] [Full Text] [Related]

  • 15. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007 Dec 27; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 16. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H, Isaji S, Yamagiwa K, Tabata M, Nemoto A, Sakurai H, Usui M, Uemoto S.
    J Hepatobiliary Pancreat Surg; 2006 Dec 27; 13(2):123-30. PubMed ID: 16547673
    [Abstract] [Full Text] [Related]

  • 17. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J.
    Liver Transpl; 2008 Mar 27; 14(3):272-8. PubMed ID: 18306328
    [Abstract] [Full Text] [Related]

  • 18. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
    Sugawara Y, Tamura S, Makuuchi M.
    Dig Dis; 2007 Mar 27; 25(4):310-2. PubMed ID: 17960065
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
    Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, Compagnon P, Vanlemmens C, Dumortier J, Dharancy S, Gugenheim J, Bernard PH, Adam R, Radenne S, Muscari F, Conti F, Hardwigsen J, Pageaux GP, Chazouillères O, Salame E, Hilleret MN, Lebray P, Abergel A, Debette-Gratien M, Kluger MD, Mallat A, Azoulay D, Cherqui D, Liver Transplantation French Study Group.
    Gastroenterology; 2012 Oct 27; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
    [Abstract] [Full Text] [Related]

  • 20. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, Harada N, Yamashita Y, Sugimachi K, Kayashima H, Iguchi T, Maehara Y.
    Transplantation; 2009 Feb 27; 87(4):531-7. PubMed ID: 19307789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.